Validity and reliability evidence of a point of care assessment of salivary cortisol and
Exercise
Psychophysiology
Saliva
Stress
Journal
PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425
Informations de publication
Date de publication:
2020
2020
Historique:
received:
09
08
2019
accepted:
06
12
2019
entrez:
16
1
2020
pubmed:
16
1
2020
medline:
16
1
2020
Statut:
epublish
Résumé
The iPro Cube is a small portable point-of-care device designed to analyse salivary markers of stress in a user-friendly manner (e.g., fast, convenient). Our aim was to test the reliability and validity of the iPro Cube to measure salivary cortisol and The study was a repeated measures, pre-registered design, and statistical framework that incorporated prior knowledge directly into the estimation process. Twenty-nine individuals (age = 27.4 ± 6.6 y; body-mass = 70.8 ± 11.3 kg; height = 1.74 ± 0.92 m; 18 males) completed a single PWC Correlation between the iPro Cube and laboratory-based assessments of salivary cortisol was moderate-to-large (0.53 > The iPro Cube is capable of taking measures of salivary cortisol that are moderately correlated to values obtained via ELISA immunoassay, however the unit underestimates salivary cortisol and overestimates salivary -amylase at rest and post-moderate intensity exercise. It is recommended that researchers continue using standard laboratory techniques to assess these salivary stress markers.
Identifiants
pubmed: 31938581
doi: 10.7717/peerj.8366
pii: 8366
pmc: PMC6954686
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e8366Informations de copyright
©2020 Ducker et al.
Déclaration de conflit d'intérêts
The authors declare there are no competing interests.
Références
Neurosci Biobehav Rev. 2017 Dec;83:657-677
pubmed: 28864234
J Sports Sci. 2008 Apr;26(6):653-61
pubmed: 18344136
J Strength Cond Res. 2015 Nov;29 Suppl 11:S10-23
pubmed: 26506170
Clin Endocrinol (Oxf). 2012 Nov;77(5):645-51
pubmed: 22812714
Sports Med. 2015 May;45(5):713-26
pubmed: 25655373
J Sports Med Phys Fitness. 2017 Dec;57(12):1680-1686
pubmed: 27849116
Psychoneuroendocrinology. 2009 Feb;34(2):163-71
pubmed: 19095358
Int J Sports Physiol Perform. 2015 Jul;10(5):613-7
pubmed: 25561572
J Sci Med Sport. 2011 Sep;14(5):424-34
pubmed: 21474377
Res Sports Med. 2015;23(2):140-50
pubmed: 25639912
Eur J Appl Physiol. 2015 May;115(5):1015-27
pubmed: 25557386
Psychoneuroendocrinology. 2011 May;36(4):449-53
pubmed: 21295411
Med Sci Sports Exerc. 1999 Feb;31(2):348-51
pubmed: 10063826
Physiol Behav. 2007 Jan 30;90(1):43-53
pubmed: 17055006
Int J Sports Physiol Perform. 2011 Sep;6(3):396-407
pubmed: 21911864
Psychol Methods. 2012 Sep;17(3):313-35
pubmed: 22962886
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
J Strength Cond Res. 2002 May;16(2):286-9
pubmed: 11991783
Scand J Clin Lab Invest. 2005;65(5):433-6
pubmed: 16081365
J Int Soc Sports Nutr. 2017 Aug 10;14:27
pubmed: 28811748
Int J Sports Physiol Perform. 2016 Jul;11(5):574-80
pubmed: 26389779
Stress. 2004 Mar;7(1):29-37
pubmed: 15204030
Neuroimmunomodulation. 2009;16(5):284-9
pubmed: 19571589
Psychol Methods. 2017 Jun;22(2):240-261
pubmed: 26690773
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
J Sci Med Sport. 2010 Sep;13(5):496-502
pubmed: 20005170
Biol Psychol. 2012 Dec;91(3):342-8
pubmed: 22954623
Psychoneuroendocrinology. 2017 Sep;83:25-41
pubmed: 28578301
Psychoneuroendocrinology. 2009 May;34(4):486-96
pubmed: 19249160
Sports Med. 1985 May-Jun;2(3):159-64
pubmed: 3848048
BMB Rep. 2015 Apr;48(4):209-16
pubmed: 25560699
Psychoneuroendocrinology. 2009 May;34(4):469-85
pubmed: 19155141